RxDoctor Payments Data

Jason Meier, MD

Otolaryngology/Facial Plastic Surgery · Jacksonville, FLNPI 1396890869

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,333 of the $1,637 with a category attached, or 81.4%. 10 manufacturers reported payments, led by AbbVie at 24.7% of the total. Reporting peaked in 2019 at $636 and has fallen 52.2% since, to $304 in 2025. That places this record below the midpoint for otolaryngology/facial plastic surgery clinicians in FL, where the typical reported total is $2,474.

$1,637in general payments, 2019–2025

Across 49 payments — averaging $33.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$404
  • KARL Storz Endoscopy-america$270
  • Galderma Laboratories, L.p.$226
  • Regeneron Healthcare Solutions, Inc.$211
  • Sanofi$165
  • Medtronic$141
  • plus $220 from 4 others

What the payments were for

  • Food & beverage$1,33381%
  • Education$342%
  • Gifts$27016%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,637 in reported general payments places this provider in the 40th percentile of 48 otolaryngology/facial plastic surgery providers in Florida.

See all otolaryngology/facial plastic surgery providers in Florida

Medicare billing

Part B allowed, 2024
$260,410
Medicare patients
715
Services billed
2,003

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ipratropium Bromide198$5,799
Montelukast Sodium216$2,987
Fluocinolone Acetonide Oil33$1,813
Fluticasone-SalmeterolFluticasone Propion/Salmeterol16$1,726
Famotidine106$1,656
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth13$1,376
Pantoprazole Sodium120$1,288
Azelastine Hcl14$485
Methylprednisolone50$419
Fluticasone Propionate18$390
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav37$377
Prednisone61$184
Baclofen31$122
Mupirocin18$108
Levofloxacin15$102

Paid to pharmacies, not to this prescriber.

Other otolaryngology/facial plastic surgery in Jacksonville

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →